Evidence map›Paper›PMID 41058925›Full record

ArticleVirus evolution2025

Rapid glycoprotein evolution enables variant interactions in herpes simplex virus type 1.

Thomas Höfler, Michaela Zeitlow, Ji Y Kim, Emanuel Wyler, Jakob Trimpert

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas HöflerInstitut für Virologie, Fachbereich Veterinärmedizin, Freie Universität Berlin, Robert-von-Ostertag-Straße 7, 14163 Berlin, Germany.ORCID https://orcid.org/0000-0001-7486-5582
Michaela ZeitlowInstitut für Virologie, Fachbereich Veterinärmedizin, Freie Universität Berlin, Robert-von-Ostertag-Straße 7, 14163 Berlin, Germany.
Ji Y KimInstitut für Virologie, Fachbereich Veterinärmedizin, Freie Universität Berlin, Robert-von-Ostertag-Straße 7, 14163 Berlin, Germany.
Emanuel WylerBerlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Hannoversche Straße 28, 10115 Berlin, Germany.
Jakob TrimpertInstitut für Virologie, Fachbereich Veterinärmedizin, Freie Universität Berlin, Robert-von-Ostertag-Straße 7, 14163 Berlin, Germany.ORCID https://orcid.org/0000-0003-1616-0810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycoproteins cover the surface of enveloped viruses such as herpes simplex virus 1 (HSV-1). Whilst essential for cellular attachment and entry, they also are excellent targets for host immune responses. This dichotomy culminates in an evolutionary struggle in which receptor recognition and immune escape are intricately balanced. Herpesviruses feature a variety of different glycoproteins with diverse molecular functions. Here, we describe the rapid evolution of HSV-1 towards syncytial plaque phenotypes in Vero cell culture, as well as anti-gD antibody resistance in human foreskin fibroblast cells. Using a mild hypermutator virus to accelerate experimental evolution, we identified multiple genetic variants leading to syncytial plaques. Strikingly, these variants differentially affect interactions within viral populations. Whilst gK mutants engage in collective syncytia formation upon entry, accelerate superinfection exclusion and maintain fitness advantages at high multiplicities of infection, gB and gD mutants do not. Furthermore, we find gE mutants which lead to mouse anti-gD antibody resistance and cross protect wt virus in mixed populations. Our findings suggest complex social interactions within herpesvirus populations and illustrate the evolutionary plasticity and diverse function of their glycoproteins.

Indexed as

evolutionglycoproteinsherpes simplexhypermutatorsociovirologyvariant interactionviruses

Identifiers

PMID41058925
PMCPMC12499918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.